2020
DOI: 10.3389/fbioe.2020.00882
|View full text |Cite
|
Sign up to set email alerts
|

Cell Reprogramming With CRISPR/Cas9 Based Transcriptional Regulation Systems

Abstract: The speed of reprogramming technologies evolution is rising dramatically in modern science. Both the scientific community and health workers depend on such developments due to the lack of safe autogenic cells and tissues for regenerative medicine, genome editing tools and reliable screening techniques. To perform experiments efficiently and to propel the fundamental science it is important to keep up with novel modifications and techniques that are being discovered almost weekly. One of them is CRISPR/Cas9 bas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 34 publications
(17 citation statements)
references
References 147 publications
0
17
0
Order By: Relevance
“…As in vitro transcription/translation platforms are easily adaptable to high-throughput formats [18,19], the parallel testing of multiple Cas9 enzymes with altered properties could be achieved. In addition to testing mutant Cas9 variants, the system might also be useful to assess the properties of Cas9 fusion proteins for different purposes, e.g., base editing [20], epigenetic modification [21], or transcriptional activation/repression [22]. Once a robust Cas9 nuclease has been identified for a particular purpose, the BYL system can be used to produce RNPs for subsequent DNA-free delivery to the appropriate target cell/tissue.…”
Section: Discussionmentioning
confidence: 99%
“…As in vitro transcription/translation platforms are easily adaptable to high-throughput formats [18,19], the parallel testing of multiple Cas9 enzymes with altered properties could be achieved. In addition to testing mutant Cas9 variants, the system might also be useful to assess the properties of Cas9 fusion proteins for different purposes, e.g., base editing [20], epigenetic modification [21], or transcriptional activation/repression [22]. Once a robust Cas9 nuclease has been identified for a particular purpose, the BYL system can be used to produce RNPs for subsequent DNA-free delivery to the appropriate target cell/tissue.…”
Section: Discussionmentioning
confidence: 99%
“…When directed to DNA regions using synthetic single guide RNAs (sgRNA), this increases the expression of endogenous genes of interest. Thus, the use of this technology with all its derivatives is of great interest for the fields of cell reprogramming and regenerative medicine [156,157].…”
Section: Crispr-cas9mentioning
confidence: 99%
“…VP64 is a tetramer of VP16–a well-characterized herpes simplex virus transcription activator. It is among the first generation of CRISPRa systems and demonstrates a strong induction of activation in many experiments [ 63 ]. First-generation CRISPRa systems contain dCas9 fused with transactivator and sgRNA.…”
Section: Activation Of Defense Genes Through Crispr Activation (Crispra)mentioning
confidence: 99%